Literature DB >> 14511118

Regulation of microglial inflammatory response by histone deacetylase inhibitors.

Tiina Suuronen1, Jari Huuskonen, Rea Pihlaja, Sergiy Kyrylenko, Antero Salminen.   

Abstract

The activation of microglial cells is involved in the pathogenesis of a variety of neurodegenerative diseases, stroke and traumatic brain injuries. Recent studies suggest that protein acetylation can affect the extent of inflammatory responses. Our aim was to elucidate whether histone deacetylase inhibitors, inducers of protein hyperacetylation, regulate the inflammatory response in neural models of inflammation in vitro and whether neurone-glia interactions affect this regulation. Interestingly, we observed that histone deacetylase inhibitors, such as trichostatin A (TSA) and suberoylanilide hydroxamic acid, strongly potentiated the lipopolysaccharide (LPS)-induced inflammatory response in murine N9 and rat primary microglial cells as well in neural co-cultures and hippocampal slice cultures. TSA clearly potentiated the LPS-induced expression of interleukin (IL)-6 and inducible nitric oxide synthase mRNAs, as well as the secretion of cytokines IL-6, tumour necrosis factor-alpha and macrophage inflammatory protein (MIP)-2, and nitric oxide (NO). Co-culture and slice culture experiments showed that the presence of astrocytes and neurones did not stimulate or prevent the pro-inflammatory potentiation induced by histone deacetylase inhibitor in microglial cells. The potentiation of cytokine and NO responses was blocked by the nuclear factor kappa B (NF-kappa B) inhibitors caffeic acid phenethyl ester and helenalin, demonstrating that the NF-kappa B signalling pathway is involved. The DNA-binding activity of the NF-kappa B complex was strongly increased by LPS treatment but not enhanced by TSA. This suggests that potentiation of the inflammatory response is not dependent on the level of cytoplasmic NF-kappa B activation or DNA-binding activity but that site of action may be at the level of transcriptional regulation. Our results suggest that environmental stresses, ageing, diet and diseases that regulate protein acetylation status may also affect the inflammatory response.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14511118     DOI: 10.1046/j.1471-4159.2003.02004.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  41 in total

Review 1.  Histone deacetylase (HDAC) inhibition as a novel treatment for diabetes mellitus.

Authors:  Dan P Christensen; Mattias Dahllöf; Morten Lundh; Daniel N Rasmussen; Mette D Nielsen; Nils Billestrup; Lars G Grunnet; Thomas Mandrup-Poulsen
Journal:  Mol Med       Date:  2011-01-25       Impact factor: 6.354

Review 2.  Microglial phenotype and adaptation.

Authors:  B J L Eggen; D Raj; U-K Hanisch; H W G M Boddeke
Journal:  J Neuroimmune Pharmacol       Date:  2013-07-25       Impact factor: 4.147

3.  Valproic acid alleviates memory deficits and attenuates amyloid-β deposition in transgenic mouse model of Alzheimer's disease.

Authors:  Ai-Guo Xuan; Xue-Bing Pan; Peng Wei; Wei-Dong Ji; Wen-Juan Zhang; Ji-Hong Liu; Le-Peng Hong; Wen-Liang Chen; Da-Hong Long
Journal:  Mol Neurobiol       Date:  2014-05-23       Impact factor: 5.590

4.  Combined treatment with GSNO and CAPE accelerates functional recovery via additive antioxidant activities in a mouse model of TBI.

Authors:  Mushfiquddin Khan; Anandakumar Shunmugavel; Tajinder S Dhammu; Hamza Khan; Inderjit Singh; Avtar K Singh
Journal:  J Neurosci Res       Date:  2018-07-19       Impact factor: 4.164

5.  Epigenetics: an expanding new piece of the stroke puzzle.

Authors:  William J Pearce
Journal:  Transl Stroke Res       Date:  2011-09       Impact factor: 6.829

Review 6.  Gene regulation and genetics in neurochemistry, past to future.

Authors:  Steven W Barger
Journal:  J Neurochem       Date:  2016-10-17       Impact factor: 5.372

7.  Constitutive repression of interleukin-1alpha in endothelial cells.

Authors:  Gregory J Brunn; Soheyla Saadi; Jeffrey L Platt
Journal:  Circ Res       Date:  2008-02-21       Impact factor: 17.367

8.  Blocking TH17-polarizing cytokines by histone deacetylase inhibitors in vitro and in vivo.

Authors:  Daniela Bosisio; Marisa Vulcano; Annalisa Del Prete; Marina Sironi; Valentina Salvi; Laura Salogni; Elena Riboldi; Flavio Leoni; Charles A Dinarello; Giampiero Girolomoni; Silvano Sozzani
Journal:  J Leukoc Biol       Date:  2008-09-09       Impact factor: 4.962

Review 9.  Organotypic Hippocampal Slices as Models for Stroke and Traumatic Brain Injury.

Authors:  Qian Li; Xiaoning Han; Jian Wang
Journal:  Mol Neurobiol       Date:  2015-07-30       Impact factor: 5.590

10.  Histone deacetylase-3 activation promotes tumor necrosis factor-alpha (TNF-alpha) expression in cardiomyocytes during lipopolysaccharide stimulation.

Authors:  Huaqing Zhu; Limei Shan; Peter W Schiller; Antonello Mai; Tianqing Peng
Journal:  J Biol Chem       Date:  2010-01-22       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.